Other Names for this Disease
- Destombes-Rosaï-Dorfman disease
- Rosaï-Dorfman disease
- Rosaï-Dorfman-Destombes disease
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Your QuestionWhat is the best treatment for Rosai-Dorfman? A biopsy was done about 2 years ago. The doctor is considering radiation therapy. I have a lesion deep in my pelvic bone.
We have identified the following information that we hope you find helpful. If you still have questions, please contact us.
In many cases, the signs and symptoms of Rosai-Dorfman disease go away without any treatment (spontaneous remission) within months or a few years. When possible, the preferred course of management is continuous observation without treatment. Many individuals will not require therapy, but in some cases, various treatment options may become necessary. Treatment of the condition is then typically directed toward the specific symptoms that the affected individual has. Some individuals may need surgical removal of histiocytic lesions. In more serious cases, treatment options have included therapy with certain drugs including steroids (e.g., prednisone), alfa-interferon (a man-made copy of a protein that is normally made by the body in response to infection), chemotherapy and radiation therapy. These treatments have improved symptoms in some individuals, but in others they have not been effective. Other treatment is symptomatic and supportive.
Last updated: 8/20/2013
- Rosai-Dorfman Disease. NORD. 2014; http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1122/viewAbstract. Accessed 8/27/2015.
- Tebbi CK, Arceci RJ, Loew TW. Histiocytosis. Medscape Reference. April 2012; http://emedicine.medscape.com/article/958026-overview. Accessed 7/22/2013.
- Rosai J. Rosai-Dorfman Disease. National Organization for Rare Disorders (NORD). 2011; http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1122/viewAbstract. Accessed 7/22/2013.